Dr Ali is a medical oncologist competent in managing a wide range of solid cancers with special interest in management of lung, melanoma and colorectal cancers.
After finishing oncology training at the Royal Prince Alfred Hospital in Sydney, he obtained FRACP Specialist Fellowship in 2011. Dr Ali commenced his elective year as a clinical trial fellow at the Westmead Hospital, where he coordinated number of Phase I to III trials. Dr Ali was instrumental in setting up melanoma and immunotherapy services at the Canberra Hospital. His research interests include immune oncology, predictive biomarkers of immune checkpoint inhibitor, and health service delivery. He is currently pursuing translational research in collaboration with labs in ANU medical school and University of Canberra to identify patients who benefit from immune checkpoint inhibitor and predict toxicity. He has published his research findings in several high impact journals and presented in national and international conferences.
Dr Ali consults and treats patients at Icon Cancer Centre Midland, in addition to his appointment as Head of Medical Oncology at St John of God Hospital Midland.